XCUR Stock Summary and Trading Ideas (Exicure | NASDAQ:XCUR)

Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.

Exicure trades on the NASDAQ stock market under the symbol XCUR.

As of December 24, 2025, XCUR stock price climbed to $6.00 with 18,811 million shares trading.

XCUR has a beta of 0.31, meaning it tends to be less sensitive to market movements. XCUR has a correlation of 0.00 to the broad based SPY ETF.

XCUR has a market cap of $38.24 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, XCUR traded as high as $36.00 and as low as $1.44.

The top ETF exchange traded funds that XCUR belongs to (by Net Assets): VXF, IWC.

XCUR has underperformed the market in the last year with a price return of -69.3% while the SPY ETF gained +17.3%. However, in the short term, XCUR had mixed performance relative to the market. It has outperformed in the last 3 months, returning +70.9% vs +4.4% return in SPY. But in the last 2 weeks, XCUR shares have been beat by the market, returning -17.7% compared to an SPY return of +1.4%.

XCUR support price is $5.11 and resistance is $6.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XCUR shares will trade within this expected range on the day.